Regulatory submissions and approvals
Navigate the documentation requirements for IND/CTA submissions, regulatory authority communications, and approval documentation that must be in place before enrollment.
The week before first patient
Marcus Thompson, the lead Clinical Research Coordinator at Piedmont Clinical Research Center in Charlotte, North Carolina, had been preparing for this moment for months. The CLARITY-HF trial, a Phase 2 study of an investigational heart failure therapy, was finally ready to enroll its first participant. The protocol was approved. The site was trained. The investigational product sat in the pharmacy refrigerator, temperature-monitored and waiting. A promising candidate, Mrs. Evelyn Rodriguez, had completed screening and met all eligibility criteria.